“I have a feeling even an MHRA approval won’t result in more than the $2+ a share we attained almost 3 years ago on mere rumor of TLD.”
Exactly right. I have said this before that MHRA approval alone will not get us back to $2 anymore. Without a big pharma partner and the credibility they lend to NWBO, we are not going anywhere. 2023 will be another lost year!